NASDAQ · Analyst Forecast

Lexaria Bioscience Corp. (LEXX) Stock Forecast & Price Target

$4.18 NASDAQ: LEXX Market Cap $6.91M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 18, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Lexaria Bioscience Corp. (LEXX), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Lexaria Bioscience Corp., analysts forecast revenue rising from $496,923 in 2024 to $70.19M in 2029; the average estimate for 2029 earnings per share is $20.10; 2 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$4.18
Consensus targetThe average of the price targets analysts have published.$1.50
Median targetThe middle target, less affected by a single outlier.$1.50
Highest targetThe most optimistic published target.$1.50
Lowest targetThe most pessimistic published target.$1.50
Difference from priceHow far the consensus target sits from today’s price.-64.1%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2024$492,384$496,923$501,4611
2025$629,059$669,000$708,9402
2026$20,000$20,000$20,0001
2027$1.40M$1.40M$1.40M1
2028$1.58M$1.58M$1.58M1
2029$70.19M$70.19M$70.19M1

Earnings per share forecast

YearLowAverageHighAnalysts
2024−$0.51−$0.51−$0.511
2025−$10.65−$10.20−$9.752
2026−$4.05−$4.05−$4.051
2027−$4.65−$4.65−$4.651
2028−$4.20−$4.20−$4.201
2029$20.10$20.10$20.101

Lexaria Bioscience Corp. (LEXX) forecast — frequently asked questions

What is the analyst price target for Lexaria Bioscience Corp.?

Analysts covering Lexaria Bioscience Corp. (LEXX) have a consensus price target of $1.50, 64.1% below the current price of $4.18. Published targets range from $1.50 to $1.50. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Lexaria Bioscience Corp.'s earnings?

The average analyst estimate for Lexaria Bioscience Corp. (LEXX) earnings per share in 2029 is 20.10, with individual estimates between 20.10 and 20.10.

How much revenue is Lexaria Bioscience Corp. expected to make?

Analysts forecast Lexaria Bioscience Corp. (LEXX) revenue of $70.19M in 2029, based on 1 published estimates.

How many analysts cover LEXX?

2 analysts contribute estimates for Lexaria Bioscience Corp. (LEXX). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.